Deborah Margatho

No ORCID on file · 6 papers in corpus · active 2018-2022

Study types

  • article 3
  • book-chapter 2
  • rct 1

Condition tags

  • endometriosis 5
  • chronic_pelvic_pain 4
  • dysmenorrhea 3
book-chapter 2022
·doi:10.53268/bkf22040509

A endometriose é uma doença pélvica benigna e inflamatória, em que há tecido endometrial extrauterino. O tratamento visa reduzir a inflamação. O objetivo deste estudo foi avaliar os escores de dor pélvica crônica, dismenorreia, níveis séric…

article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2097658

OBJECTIVES: The purpose of the study was to assess the experiences of male partners of women with endometriosis-associated pain after medical treatment in their everyday lives. METHODS: We conducted a phenomenological study based on semi-s…

book-chapter 2021
·doi:10.1016/b978-0-12-818988-7.00036-4
article 2020
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2020.1725461

Objectives: The aims of the study were to correlate endometriosis-associated pain, evaluated by visual analogue scale (VAS) scores, with serum levels of etonogestrel (ENG), levonorgestrel (LNG), CA-125 and soluble CD23 in users of the ENG i…

article 2018
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2018.1531117

OBJECTIVE: The aim of the study was to assess the serum levels of the following biomarkers in women with endometriosis-associated pelvic pain before and after six months of using the etonogestrel (ENG) contraceptive implant or the 52 mg lev…

rct 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.07.003

OBJECTIVE: To assess the efficacy of an etonogestrel (ENG)-releasing contraceptive implant or the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) in the control of endometriosis-associated pelvic pain. DESIGN: Noninferiority r…